vascular-surgery-2018-scientifictracks

38 / 65

Page 62
May 24-25, 2018
London, UK
Vascular Surgery 2018
3 rd Edition of World Congress & Exhibition on
Vascular Surgery
Journal of Vascular and Endovascular Therapy
ISSN: 2573-4482
BACKGROUND: The endovascular treatment of peripheral arterial
occlusive disease (PAOD) has undergone rapid evolution during
the last years, characterized by the availability of a plethora of
new devices and techniques that make an increasing number of
lesions (technically) amenable to an “endo-first” approach. The
interventionalist is now confronted with a multitude od options to
cross and treat a lesion, but surprisingly little scientific evidence
exists as to which method should be preferred over another, and
in which lesion. For example, the notion that primary nitinol stents
are superior to balloon angioplasty is based solely on three RCTs,
the superiority of drug eluting stent over bare stent on a subgroup
in one RCT, and the difference between drug-eluting balloons and
nitinol stenting has never been addressed in an RCT.
LEARNING OBJECTIVES: This course will provide an overview of
available endovascular techniques, including balloon angioplasty,
bare stent implantation, stentgrafts, drug-eluting balloons, and
drug-eluting stents. Region by region, the available literature
concerning experience, expected primary patencies, and
comparisons (where available) between the available methods
will be appraised. Questions for which evidence is urgently needed
but not available will be defined. For each region, a decision tree
based upon the available evidence will be drafted and opened for
discussion.
The following techniques will be covered:
• Balloon angioplasty
• Bare nitinol stents
• Drug-eluting stents
• Sentgrafts
• Drug-eluting balloons
Recent Publications
1. Self-expanding nitinol stents of high versus low chronic
outward force in de novo femoropopliteal occlusive
arterial lesions (BIOFLEX-COF trial): study protocol for
a randomized controlled trial. Wressnegger A, Kaider
A, Funovics MA. Trials. 2017 Dec 14;18(1):594. doi:
10.1186/s13063-017-2338-0.
2. Paclitaxel-Eluting Balloon Versus Standard Balloon
Angioplasty in In-Stent Restenosis of the Superficial
Femoral and Proximal Popliteal Artery: 1-Year Results
of the PACUBA Trial. Kinstner CM, Lammer J, Willfort-
EhringerA,MatzekW, GschwandtnerM, JavorD, Funovics
M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F.
JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi:
10.1016/j.jcin.2016.04.012.
3. Treatment of the aorto-iliac segment in complex lower
extremity arterial occlusive disease. Wressnegger A,
Kinstner C, FunovicsM. J Cardiovasc Surg (Torino). 2015
Feb;56(1):73-9. Epub 2014 Dec 5.
4. Endovascular repair of thoracoabdominal aortic
aneurysms with a novel multibranch stent-graft design:
preliminary experience. Kinstner C, Teufelsbauer H,
NeumayerC, DomenigC,WressneggerA,Wolf F, Funovics
M. J Cardiovasc Surg (Torino). 2014 Aug;55(4):543-50.
Epub 2014 Jul 10.
5. [Endovascular interventions for multiple trauma].
Kinstner C, Funovics M. Radiologe. 2014 Sep;54(9):893-
9. doi: 10.1007/s00117-013-2638-7. German
Biography
Martin Funovics is an interventional radiologist and has been working in all
fields of endovascular treatment and oncologic IR for over 20 years. He has
authored over 90 peer-reviewed publications both in clinical IR as well as
in basic research in vascular and tumor biology. He has co-developed nov-
el stent graft designs for aortic repair and performed several first-in-man
procedures of novel devices. He is PI of the first (ongoing) RCT assessing
chronic outward force between different nitinol stents in peripheral arterial
disease.
Endovascular treatment of peripheral arterial disease in 2018:
Which technology to use, and why
Martin A Funovics
Medical University of Vienna, Austria
Martin A Funovics, J Vasc Endovasc Therapy 2018, Volume 3
DOI: 10.21767/2573-4482-C1-002